Medical Device Labeling, UDI and CE Marking: Keep Claims Aligned
Updated: 4 days ago
Reviewed by Aaron Lyon, President of A.P. Lyon and former Director of Quality Assurance and International Regulatory, with more than 30 years in medical device quality. Last reviewed November 10, 2026.
How do labeling approval, UDI and CE-marking activities relate?
Select Label Review/Approval for controlled labels and IFU, UDI for identifiers and database information, and CE Marking for the broader EU conformity workflow. Artwork approval, identifier assignment and conformity assessment are connected but distinct. Verify claims against supporting evidence before release.
Labels and instructions communicate device identity, intended use and important information to users. UDI and registration records support identification, while CE marking involves a broader conformity-assessment framework. These activities intersect, but label approval alone does not establish that all market-access obligations have been met.
Decision table: match the gap to the evidence
Situation | Decision | Evidence to retain |
Label or IFU changes | Assess configuration, claims and controlled approval. | Artwork, reviewers and effective revision. |
Device identity changes | Assess identifiers and database implications. | UDI decision and reviewed records. |
EU market conformity is assessed | Determine applicable classification and route. | Technical evidence and conformity decisions. |
Review the complete labeling set
Identify unit, box and shipper labels, instructions for use and the versions relevant to each market. Check consistency with approved claims, device configurations and supporting evidence. A shelf-life statement should align with the stability evidence, and changes in intended use or warnings should be assessed with the relevant technical and regulatory functions.
Connect identifiers and market records
Define responsibilities for identifier assignment, data entry, review and change management. Compare device identity and configuration across labels and database records. For EU activities, assess classification, technical documentation and the applicable conformity route separately from the mechanics of label artwork approval.
Worked example: a fictional planning decision
A fictional device extends its claimed shelf life. The team checks the supporting evidence, label and IFU revisions, affected stock and relevant identifier/database implications. The artwork owner cannot establish the claim simply by changing the printed date. The controlled release records connect the approved statement with the evidence and configurations it covers.
Implementation record: make the decision reviewable
Create a label-set matrix listing unit, box, shipper and IFU versions by model and market. Verify intended purpose, warnings, storage and shelf-life statements against approved sources. Check identifiers across artwork and relevant database records, distinguishing device and production information. Record change assessments, approval authority, effective dates and inventory disposition. For EU conformity, keep the route and technical-documentation decisions visible instead of treating the CE symbol as a graphical approval.
Applicability, exceptions and conclusion limits
FDA's UDI overview describes labeling and GUDID responsibilities with exceptions and alternatives; confirm actual applicability. U.S. identifiers and EU obligations should not be assumed identical. Changes can affect more than artwork, while some changes may have limited impact if justified. Device-specific classification and market arrangements need current assessment; one checklist cannot settle every route.
Choose documentation by the missing workflow
The labeling bundle contains Label Review/Approval, UDI, Product Stability/Shelf Life and CE Marking. Select an individual procedure if only one workflow is missing. Downloads do not issue a UDI, submit database information, provide conformity certification or support an unproven claim. If approved controls already work, correct the actual claim, configuration or data mismatch before adding documentation.
Use label review and approval for label levels, IFU checks, approvals and controlled changes.
Use UDI documentation for identifier assignment, labeling and associated database records.
Use CE-marking documentation to organize classification, technical evidence and conformity-assessment activities.
Compare the labeling bundle for connected label, UDI, shelf-life and CE-marking procedures.
Common mistakes and an additional practical check
Avoid assuming the UDI or CE symbol is the whole compliance task. Verify the applicable duties and current requirements for the device and market before approving labels or registration changes.
A packaging revision may require an artwork change without changing the device’s intended use. Another revision may introduce a new claim. The review should distinguish those effects and route the second change through the appropriate evidence and regulatory assessment.
Review checklist before approving the workflow
Identify configurations, languages and markets.
Review labels and IFU against approved claims.
Check shelf-life and other evidence-dependent statements.
Align identifiers with database records.
Assess changes for labeling and market-access impacts.
Inside the supplied document: controlled labeling proofs
Source: supplied A.P. Lyon SOP 7-027, revision 2, effective September 19, 2026. This is a selected preview. Image wording is retained from the source; the explanation below is adapted. It is not an executed record or a quotation from a regulation.
The Label Review and Approval source connects artwork identity with a reviewable proof. A preview of the final label alone does not show which revision was assessed or how packaging levels stayed consistent.

Selected original document text: controlled labeling proofs.
Provide representative print or electronic proofs in a suitable review form.
Identify artwork by part number and revision and distinguish proposed material.
Review legibility, placement, human factors, symbols, languages and consistency across packaging levels and the IFU.
Buyer decision: Label Review supports artwork control; UDI and CE Technical Documentation address related identifier and market-documentation tasks. Choose by the missing interface. A label approval is not a substitute for verifying the underlying claims, device configuration or destination-market requirements.
Scope and how to use this guide
This is general implementation guidance for selecting and organizing documentation. The worked planning scenarios are fictional. Separately labeled document extracts come from the supplied A.P. Lyon files identified in their source notes. Neither is a completed study or evidence of compliance. Apply the requirements for your device, process and markets, and have the responsible technical and quality personnel approve decisions. Product downloads supply editable documentation; your organization remains responsible for its implementation and evidence.
Related buyer decisions
Primary references and review date
Technical references and linked product scope checked October 13, 2026. Regulatory summaries are identified above; checklists, decision tables and fictional examples are A.P. Lyon implementation recommendations. Consult the full applicable standards and regulations before approving a project.
Publisher and editorial standards
Published by A.P. Lyon. Aaron Lyon is the company’s founder; his professional background is described on the About page. These guides use AI-assisted research and drafting. Each guide is reviewed and approved by Aaron Lyon before publication; that review does not certify applicability to your device.
Frequently asked questions
Does label approval also cover UDI and CE marking?
No. Artwork approval, UDI assignment and database records, and CE-marking conformity assessment are connected but distinct activities. Approving a label does not establish that identifiers, database entries or EU market-access obligations are complete.
What should a medical device label review check?
Review the complete labeling set for each model and market: unit, box and shipper labels and the instructions for use. Check that intended use, warnings, storage and shelf-life statements match approved claims, device configurations and the supporting evidence.
Who should own UDI information?
Define responsibilities for identifier assignment, data entry, review and change management, then compare device identity and configuration across labels and database records whenever the device or its labeling changes.
Building a complete quality system? Build Your QMS lets you choose ISO 13485 + FDA QMSR, Dual-Standard or ISO 9001:2026 procedures in one place, and applies volume discounts automatically: 20% off 5–9 procedures, 35% off 10–19, 50% off 20–39 and 60% off 40 or more.
Related guides: FDA 483 Citations for Unique Device Identification Under 21 CFR 801.20 and Part 830.
Not sure where your quality system stands? Take the free QMS gap check: about 20 questions, an instant report of your gaps by clause, and the procedures that close each one.
Just getting started? The free Startup Quality Plan shows which procedures you need now, which can wait, and how long they take to put in place.
Comments